These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 5012443

  • 1. Action and interaction of cholinergic agonists and antagonists on self-stimulation.
    Pradhan SN, Kamat KA.
    Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):321-9. PubMed ID: 5012443
    [No Abstract] [Full Text] [Related]

  • 2. Differential effects of cholinergic agonists on self-stimulation and escape behavior.
    Olds ME, Domino EF.
    J Pharmacol Exp Ther; 1969 Nov; 170(1):157-67. PubMed ID: 5351000
    [No Abstract] [Full Text] [Related]

  • 3. Comparative effects of amphetamine, scopolamine and chlordiazepoxide on self-stimulation behavior.
    Olds ME.
    Rev Can Biol; 1972 Nov; 31():Suppl:25-47. PubMed ID: 5052328
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [A neuropharmacologic analysis of the cholinergic mechanisms of self stimulation].
    Vorob'eva TM.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1974 Nov; 24(1):172-80. PubMed ID: 4480117
    [No Abstract] [Full Text] [Related]

  • 9. Effects of cholinergic agonists and antagonists on self-stimulation behavior in the rat.
    Newman LM.
    J Comp Physiol Psychol; 1972 Jun; 79(3):394-413. PubMed ID: 5054476
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reversal by levodopa of cholinergic hypersensitivity in Parkinson's disease.
    Weintraub MI, Van Woert MH.
    N Engl J Med; 1971 Feb 25; 284(8):412-5. PubMed ID: 5540479
    [No Abstract] [Full Text] [Related]

  • 12. [Reactivity of isolated rat intestine to choline potentiating compounds].
    Prozorovskiĭ VB, Khromova ON, Gladysheva NI.
    Farmakol Toksikol; 1971 Feb 25; 34(1):54-7. PubMed ID: 5563376
    [No Abstract] [Full Text] [Related]

  • 13. Cholinergic and adrenergic activating agents as antagonists of the EEG effects of hemicholinium-3.
    Dren AT, Domino EF.
    Arch Int Pharmacodyn Ther; 1968 Sep 25; 175(1):63-72. PubMed ID: 4387241
    [No Abstract] [Full Text] [Related]

  • 14. Effects of anticholinergic agents on self-stimulation.
    Pradhan SN, Kamat KA.
    Arch Int Pharmacodyn Ther; 1973 Jan 25; 201(1):16-24. PubMed ID: 4717381
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I, Noda Y, Mizuki Y, Yamada M.
    Arch Int Pharmacodyn Ther; 1984 Oct 25; 271(2):180-8. PubMed ID: 6150689
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Studies on the paradoxical interaction of physostigmine and pentobarbital on regional brain acetylcholine content of various animal species.
    Bartolini A, Domino EF.
    Arch Int Pharmacodyn Ther; 1972 Apr 25; 196():Suppl 196:129-. PubMed ID: 5052471
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.